Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · Synthetic Cannabinoids (K2 / Spice)

Synthetic Cannabinoids (K2 / Spice) in Samoa: not individually verified

Not individually verified

We have not confirmed that Synthetic Cannabinoids (K2 / Spice) specifically is scheduled in Samoa, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.

What is on record
Not confirmed. Synthetic cannabinoids are a chemically diverse category of compounds, including naphthoylindoles such as JWH-018 and AM-2201 and indazole carboxamides such as AB-FUBINACA, that act on the same cannabinoid receptors as tetrahydrocannabinol but do not share its core ring structure. None of these three probe compounds, nor the general term synthetic cannabinoids, are named in any Schedule of the Narcotics Act 1967. Because the Act's cannabinoid entries, Second Schedule items 1 and 6, are built on the specific chemical designation 'tetrahydrocannabinols' and extend only to its isomers, esters, ethers, and salts under clauses B to D, and because a naphthoylindole or an indazole carboxamide shares no such designation with a tetrahydrocannabinol, those extension clauses do not reach synthetic cannabinoids on structural grounds, regardless of shared receptor activity. The Act contains no separate generic clause covering cannabinoid receptor agonists as a functional class, unlike the named analogue regimes used in some other jurisdictions' drug laws.

Confirm directly with Samoa’s national drug authority or your own embassy before you rely on anything.

What Samoa HAS confirmed for related substances

This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.